CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
High Quality, Fast Antibody Conjugates in Complete ELISA Kits
Drug Discovery, Development and Delivery

High Quality, Fast Antibody Conjugates in Complete ELISA Kits

Every immunoassay exploits the ability of an antibody (referred to as a primary antibody) to bind selectively to a particular target antigen, which is usually pr...
Continue Reading →
Tamper-evidence – A Vital Matter of Safet
Editorial Archive

Tamper-evidence – A Vital Matter of Safet

This article, written by Alessio Bressan at IGGB and starting from the concept of falsified medicine as postulated in the European directive, focuses on the opti...
Continue Reading →
It’s Time to Address the Claims Management Disconnect
Editorial Archive

It’s Time to Address the Claims Management Disconnect

One of the fundamental pillars of the life sciences industry is the accuracy of the claims that it makes for its products. Over decades, the industry has strived...
Continue Reading →
The Use of Preclinical Models to Drive Immunotherapy Cancer Research and Combination Strategies
Drug Discovery, Development and Delivery

The Use of Preclinical Models to Drive Immunotherapy Cancer Research and Combination Strategies

The ideal treatment for any disease is one that can cure it or prevent spreading with minimal impact on the patient’s quality of life. In the case of cancer, the...
Continue Reading →
A Quality-by-design Approach to Upstream Bioprocess Interrogation and Intensification
Editorial Archive

A Quality-by-design Approach to Upstream Bioprocess Interrogation and Intensification

Efficient biopharmaceutical process development relies on the quality-by-design (QbD) paradigm. QbD is a scientific, risk-based proactive approach to drug develo...
Continue Reading →
Nested Vials for Improved Lyophilisation Efficiency
Editorial Archive

Nested Vials for Improved Lyophilisation Efficiency

Lyophilisation vials are normally washed and sterilised prior to processing and filling, which requires the use of cleanrooms, washing machines and sterilisation tun...
Continue Reading →
How to Tackle Counterfeiting; A Global Public Health Issue
Editorial Archive

How to Tackle Counterfeiting; A Global Public Health Issue

Today, counterfeit products can be found in every country and every sector of the global economy. According to international organisations like the World Health Orga...
Continue Reading →
Sterile, High-quality Components for Increased Patient Safety
Editorial Archive

Sterile, High-quality Components for Increased Patient Safety

Quality-wise, the main focus in pharmaceutical manufacturing has been primarily on the drug product and its primary container. Many pharmaceutical and packaging manu...
Continue Reading →
Get It Right the First Time Tips on Maximising Efficiency in Blister Packaging Development
Editorial Archive

Get It Right the First Time Tips on Maximising Efficiency in Blister Packaging Development

For technical products across many industries, small details are often modified without customers perceiving significant visual or functional changes. Manufacturers ...
Continue Reading →
Where are Pharmaceutical Anti-counterfeiting Technologies Headed?
Editorial Archive

Where are Pharmaceutical Anti-counterfeiting Technologies Headed?

Interpol estimates the annual turnover from pharmaceutical crime as USD 75 billion worldwide. In the US alone, the number of IPR-related seizures in the pharmaceutic...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026